Markets

Portola Pharmaceuticals Getting Closer To Key Technical Benchmark

Shutterstock photo

Portola Pharmaceuticals ( PTLA ) had its Relative Strength ( RS ) Rating upgraded from 62 to 71 Thursday -- a welcome improvement, but still shy of the 80 or higher score you look for.

[ibd-display-video id=2102289 width=50 float=left autostart=true] This proprietary rating tracks technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the last 52 weeks compares to the rest of the market.

Over 100 years of market history shows that the best stocks tend to have an RS Rating north of 80 as they launch their biggest climbs. See if Portola Pharmaceuticals can continue to show renewed price strength and hit that benchmark.

Looking For The Best Stocks To Buy And Watch? Start Here

Portola Pharmaceuticals is now considered extended and out of buy range after clearing a 41.37 buy point in a first-stage flat base . See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.

Earnings growth rose last quarter from 0% to 14%. But sales fell from -10% to -59%. Look for the next report on or around Feb. 28.

Portola Pharmaceuticals holds the No. 231 rank among its peers in the Medical-Biomed/Biotech industry group. Bioverativ ( BIVV ), Vertex Pharmaceuticals ( VRTX ) and Enanta Pharmaceuticals ( ENTA ) are among the top 5 highly rated stocks within the group.

RELATED:

Biotech And Pharmaceutical Industry And Stock News

IBD Stock Rating Upgrades: Rising Relative Strength

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PTLA RS VRTX ENTA

Other Topics

Stocks

Latest Markets Videos